Effets indesirables cutanes des interferons

Paquet, Philippe; Pierard-Franchimont, Claudine; Arrese, J. E.; Pierard, Gérald

No full text

Article (Scientific journals)

Effets indesirables cutanes des interferons

Paquet, Philippe; Pierard-Franchimont, Claudine; Arrese, J. E. et al.

2001 • In Revue Médicale de Liège, 56 (10), p. 699-702

Peer reviewed

Permalink
https://hdl.handle.net/2268/87578

PubMed
11765581

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] The alpha, beta and gamma recombinant interferons are indicated in a growing spectrum of therapeutic indications. Some unwanted side effects occur on the skin. The main clinical presentations include vesiculo-bullous sometimes infiltrated dermatitis, vasculitis, necrosis, ulceration and alopecia. Exacerbation of dermatoses such as psoriasis is also possible.

Disciplines :

Dermatology

Author, co-author :

Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard-Franchimont, Claudine ; Université de Liège - ULiège > Département des sciences cliniques > Dermatopathologie

Arrese, J. E.

Pierard, Gérald ; Université de Liège - ULiège > Département des sciences cliniques > Dermatopathologie

Language :

French

Title :

Effets indesirables cutanes des interferons

Alternative titles :

[en] Cutaneous Side Effects of Interferons

Publication date :

October 2001

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

699-702

Peer reviewed :

Peer reviewed

Available on ORBi :

since 23 March 2011

Statistics

Number of views

103 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Fumal I., Sriha B., Paquet P. Les toxidermies iatrogènes, une rançon de la quête de la santé. Rev Med Liège (sous presse).
Charon A., Bessis D. (2001) Effets secondaires cutanés locaux des interférons. Obj Peau 9:34-39.
Grob J.J., Dreno B., De la Salmoniére P. (1998) Randomized trial of interferon-α-2a as adjuvent therapy in resected primary melanoma thicker than 1.5 mm without clincally detectable node metastases. Lancet 351:1905-1910.
Duché A., Decocq G., Capron-Chivrac D. (1995) Bilan des effets indésirables de l'interféron alpha chez 72 patients traités pour hépatite C chronique active. Thérapie 50:419-423.
Sookoian S., Neglia V., Castano G. (1999) High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatits C virus. Arch Dermatol 135:1000-1001.
Miles S.A., Wang H., Cortes E. (1990) Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome. Ann Intern Med 112:582-589.
(1993) Interferon b-lb is effective in relapsing-remitting multiple sclerosis. Neurology 43:655-661.
Asnis L.A., Gaspari A.A. (1995) Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 33:393-410.
Elgart G.W., Sheremata W., Ahn Y.S. (1997) Cutaneous reactions to recombinant human interferon beta-lb: The clinical and histologic spectrum. J Am Acad Dermatol 37:553-558.
Andry P., Weber-Buisset M.J., Fraitag S. (1993) Toxidermie bulleuse á l'Introna®. Ann Dermatol Venereol 120:843-845.
Berger L., Descamps V., Marck Y. (2000) Eczéma induit par l'interféron alpha chez les malades atopiques infectés par le virus de l'hépatite C: 4 observations. Ann Dermatol Venereol 127:51-55.
Toyofuku K., Imayama S., Yasumoto S. (1994) Clinical and immunohistochemical studies of skin eruption: Relationship to administration of interferon-alpha. J Dermatol 21:727-732.
Detmar U., Agathos M., Nerl C. (1989) Allergy of delayed type to recombinant interferon-alpha 2c. Contact Derm 20:149-150.
Pigatto P.D., Bigardi A., Legori A. (1991) Allergic contact dermatitis from beta-interferon in eyedrops. Contact Dermatitis 25:199-200.
Christian M.M., Diven D.G., Sanchez R.L. (1997) Injection site vasculitis in a patient receiving interferon alpha for chronic hepatitis C. J Am Acad Dermatol 37:118-120.
Konohana A., Hasegawa Y., Kobayashi T. (1996) Cutaneous ulcerations resulting from intramuscular injections of interferon-alpha. J Am Acad Dermatol 35:788.
Webster G.F., Knobler R.L., Lublin F.D. (1996) Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol 34:365-367.
Elgart G.W., Sheremata W., Ahn Y.S. (1997) Cutaneous reactions to recombinant human interferon beta-lb: The clinical and histologica spectrum. J Am Acad Dermatol 37:553-558.
Fruland J.E., Sandermann S., Snow S.N. (1997) Skin necrosis with subsequent formation of squamous cell carcinoma after subcutaneous interferon beta injection. J Am Acad Dermatol 37:488-489.
De Ledinghen V., Brudieux E., Beylot-Barry M. (1997) Nécrose cutanée locale sévére au cours d'un traitement par interferon alpha et ribavirine pour hépatite virale chronique C. Gastroenterol Clin Biol 21:532-534.
Feldmann R., Löw-Weiser H., Duschet P. (1997) Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis. Dermatology 195:52-53.
Sickler J.B., Simmons R.A., Cobb D.K. (1998) Cutaneous necrosis associated with interferon-alfa 2b infusion. Am J Gastroenterol 93:463-464.
Virgili A., Corazza M., Lombardi A.R. (1999) Cutaneous ulcers due to interferon seem not to be related to the dosage. J Eur Acad Dermatol Venereol 113:141-143.
Philippot V., Yassir F., Balme B. (1996) Abcés sous-cutané a Mycobacterium avium-intracellulare apres injections d'interfèron alpha chez une malade traitèe pour lymphome. Ann Dermatol Venereol 123:103-105.
Bachmeyer C., Farge D., Gluckman E. (1996) Raynaud's phenomenon and digital necrosis induced by interferonalpha. Br J Dermatol 135:481-483.
Lang A.M., Norland A.M., Schuneman R.L. (1999) Localized interferon alpha-2b-induced alopecia. Arch Dermatol 135:1126-1128.
Tosti A., Misciali C., Bardazzi F. (1992) Tetogen effluvium due to recombinant interferon alpha-2b. Dermatology 184:124-125.
Fierlbeck G., Rassner G., Muller C. (1990) Psoriasis induced at the injection site of interferon gamma. Arch Dermatol 126:351-355.
Taylor C., Burns D.A., Wiselka M.J. (2000) Extensive psoriasis induced by interferon alpha treatment for chronic hepatitis C. Postgrad Med J 76:365-366.
Nikkels A.F., Delwaide J., Letawe C. (1997) Polymorphous light eruption-like lesions on sun-protected injection sites of recombinant IFN-α-2b. J Dermatol Treat 8:285.